Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamal Majidpoor

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
International Journal of Clinical Oncology|November 13, 2021
Key promoters of tumor hallmarksKeywan Mortezaee, Jamal Majidpoor
Heliyon|March 23, 2023
Anti-PD-(L)1 therapy of non-small cell lung cancer-A summary of clinical trials and current progressesKeywan Mortezaee, Jamal Majidpoor
Current Medicinal Chemistry|January 22, 2024
An Update of Extracellular Vesicle Involvement in Different Steps of Cancer Metastasis and Targeting StrategiesKeywan Mortezaee, Jamal Majidpoor
Heliyon|December 25, 2023
Alternative immune checkpoints in immunoregulatory profile of cancer stem cellsKeywan Mortezaee, Jamal Majidpoor
Life Sciences|October 20, 2022
VISTA immune regulatory effects in bypassing cancer immunotherapy: UpdatedKeywan Mortezaee, Jamal Majidpoor, Sajad Najafi
International Immunopharmacology|March 18, 2023
Indoleamine 2,3-dioxygenase 1 in circumventing checkpoint inhibitor responses: UpdatedArian Charehjoo, Jamal Majidpoor, Keywan Mortezaee
Medical Oncology (Northwood, London, England)|September 7, 2022
Epithelial-mesenchymal transition in cancer stemness and heterogeneity: updatedKeywan Mortezaee, Jamal Majidpoor, Ebrahim Kharazinejad
Life Sciences|August 21, 2019
Cancer stem cell (CSC) resistance driversMasoud Najafi, Keywan Mortezaee, Jamal Majidpoor
Life Sciences|November 16, 2019
Stromal reprogramming: A target for tumor therapyMasoud Najafi, Keywan Mortezaee, Jamal Majidpoor
Expert Reviews in Molecular Medicine|October 21, 2022
Extracellular vesicle isolation, purification and evaluation in cancer diagnosisKeywan Mortezaee, Jamal Majidpoor, Fardin Fathi
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
International Journal of Clinical Oncology|November 13, 2021
Key promoters of tumor hallmarksKeywan Mortezaee, Jamal Majidpoor
Heliyon|March 23, 2023
Anti-PD-(L)1 therapy of non-small cell lung cancer-A summary of clinical trials and current progressesKeywan Mortezaee, Jamal Majidpoor
Current Medicinal Chemistry|January 22, 2024
An Update of Extracellular Vesicle Involvement in Different Steps of Cancer Metastasis and Targeting StrategiesKeywan Mortezaee, Jamal Majidpoor
Heliyon|December 25, 2023
Alternative immune checkpoints in immunoregulatory profile of cancer stem cellsKeywan Mortezaee, Jamal Majidpoor
Life Sciences|October 20, 2022
VISTA immune regulatory effects in bypassing cancer immunotherapy: UpdatedKeywan Mortezaee, Jamal Majidpoor, Sajad Najafi
International Immunopharmacology|March 18, 2023
Indoleamine 2,3-dioxygenase 1 in circumventing checkpoint inhibitor responses: UpdatedArian Charehjoo, Jamal Majidpoor, Keywan Mortezaee
Medical Oncology (Northwood, London, England)|September 7, 2022
Epithelial-mesenchymal transition in cancer stemness and heterogeneity: updatedKeywan Mortezaee, Jamal Majidpoor, Ebrahim Kharazinejad
Life Sciences|August 21, 2019
Cancer stem cell (CSC) resistance driversMasoud Najafi, Keywan Mortezaee, Jamal Majidpoor
Life Sciences|November 16, 2019
Stromal reprogramming: A target for tumor therapyMasoud Najafi, Keywan Mortezaee, Jamal Majidpoor
Expert Reviews in Molecular Medicine|October 21, 2022
Extracellular vesicle isolation, purification and evaluation in cancer diagnosisKeywan Mortezaee, Jamal Majidpoor, Fardin Fathi
Pageof 8